Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 1 Issue: 1, January 2013

Editorial

Volume:1   Issue: 1
Pp: 1-1
Yuval Shaked
DOI: 10.2174/2212697X01999131126150331
Published on: 26 November, 2013

New Purine Nucleoside Analogs for Acute Lymphoblastic Leukemia

Volume:1   Issue: 1
Pp: 2-10
Tadeusz Robak
DOI: 10.2174/2212697X01999131126150545
Published on: 16 May, 2013

Castration Resistant Prostate Cancer: From Emerging Molecular Pathways to Targeted Therapeutic Approaches

Volume:1   Issue: 1
Pp: 11-27
Patrizia Limonta, Roberta M. Moretti, Monica Marzagalli and Marina Montagnani Marelli
DOI: 10.2174/2212697X0101131204151357
Published on: 22 May, 2013

Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes

Volume:1   Issue: 1
Pp: 28-39
Monika Joshi, Zhaohai Yang, Harold Harvey, Chandra Belani and Nelson S. Yee
DOI: 10.2174/2212697X01999131126150859
Published on: 26 November, 2013

Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy

Volume:1   Issue: 1
Pp: 40-53
Yasuo Imai, Hidetsugu Yamagishi, Yuko Ono and Yoshihiko Ueda
DOI: 10.2174/2212697X01999131127163516
Published on: 16 May, 2013

Melatonin and Aromatase in Breast Cancer

Volume:1   Issue: 1
Pp: 54-64
Samuel Cos, Carlos Martínez-Campa, Alicia V. González, Virginia Alvarez-García, Carolina Alonso-González, M. Dolores Mediavilla and Emilio J. Sánchez-Barceló
DOI: 10.2174/2212697X01999131127163625
Published on: 16 May, 2013

The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment

Volume:1   Issue: 1
Pp: 65-71
Bianca Maria Veneziani, Micaela Montanari, Maria Letizia Cataldo, Luigi Coppola, Agostina Nardone, Sara Corvigno, Carmine De Angelis, Grazia Arpino, Mario Giuliano, Chiara Carlomagno, Roberto Bianco and Sabino De Placido
DOI: 10.2174/2212697X113016660008
Published on: 23 October, 2013

Low Concentration of Salinomycin Prevents Regrowth and Partially Depletes Human Glioma Cells Surviving High Concentrations of Alkylating Agents

Volume:1   Issue: 1
Pp: 72-77
Zahid M. Delwar, Avramidis Dimitrios, Åke Siden, Mabel Cruz, Kajsa Paulsson and Juan Sebastian Yakisich
DOI: 10.2174/2212697X113019990002
Published on: 25 July, 2013

Case-Report: Folfoxiri Plus Bevacizumab in “Poor-Risk” Liver-Only Metastatic Colorectal Cancer: Case Report and State-of-the-Art

Volume:1   Issue: 1
Pp: 78-83
Lisa Salvatore, Fotios Loupakis, Andrea Ciarlo, Chiara Cremolini, Camilla Comin, Marta Schirripa, Luca Messerini, Federica Marmorino, Carlotta Antoniotti and Alfredo Falcone
DOI: 10.2174/2212697X0101131204152941
Published on: 04 December, 2013